摘要
目的评价抑制胃酸分泌药的药物相互作用(DDI)。方法在MCDEX数据库药物相互作用版块中检索抑制胃酸分泌药的DDI,并对其进行归纳分析。结果28种抑制胃酸分泌药在MCDEX数据库中提示存在3607对DDI,其中禁忌合用、不推荐合用、谨慎合用、关注、可以合用的分别有50、168、2214、979、196对。H2受体阻滞剂类抑酸药DDI最多,其中西咪替丁的DDI达777对。结论抑制胃酸分泌药物较易与其他药物发生相互作用,主管医师和临床药师应对其药物治疗方案进行整理和优化,避免因DDI引起药物不良反应或导致疗效降低。
Objective To evaluate and analyze the drug-drug interactions(DDI)of anti-gastric acid secretion drugs.Methods The DDI of anti-gastric acid secretion drugs in MCDEX databases’drug interaction section were selected,the results were analyze and summarized.Results 3607 Pairs of DDIs were identifined in MCDEX databases involving 28 types of anti-gastric acid secretion drugs,the DDIs that were taboo combination use,not recommended combination use,cautious combination use,pay attention to use,can be used in combination were 50,168,2214,979,and 196,respectively.The quantities of DDIs in H2 receptor antagonists was the most.Among them,the DDI of cimetidine reached 777 pairs.Conclusion The anti-gastric acid secretion drugs are more likely to interact with others,chief physician and clinical pharmacists should pay more attention on these patients to avoid the adversr drug reactions during therapy.
作者
袁勤
孙嘉婧
邹清梅
杨彪
YUAN Qin;SUN Jiajing;ZOU Qingmei;YANG Biao(Chongzhou People’s Hospital,Chengdu 611230,China;Department of Pharmacy,Dujiangyan People’s Hospital,Dujiangyan 611830,China)
出处
《现代药物与临床》
2025年第1期206-210,共5页
Drugs & Clinic
基金
中国药学会科技开发中心项目(CMEI2024KPYJ00606,CMEI2024KPYJ00809)。
关键词
抑制胃酸分泌药
药物相互作用
安全用药
H2受体阻滞剂
质子泵抑制剂
西咪替丁
anti-gastric acid secretion drugs,drug-drug interaction,medication safety,H2 receptor antagonists,proton pump inhibitors
cimetidine
作者简介
袁勤,女,主管药师,本科,研究方向为医院临床药学。E-mail:27510776@qq.com;通信作者:孙嘉婧,女,副主任药师,硕士,研究方向为医院临床药学。E-mail:178804608@qq.com。
